Publication | Open Access
Use of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes on Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion Therapy
84
Citations
20
References
2011
Year
We conclude that CGM provides similar benefits in glucose control for patients using MDI or CSII therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1